Kwality Pharmaceuticals Board Approves AGM, Director Re-appointments
Kwality Pharmaceuticals Ltd's Board of Directors met on August 8, 2026, approving key decisions including the Board Report for FY26 and the Notice for the 43rd Annual General Meeting (AGM) scheduled for August 31, 2026. The company will offer e-voting via NSDL from August 28-30, 2026, with book closure from August 25-31, 2026. The Board also approved the re-appointment of Mr. Aditya Arora and Mrs. Anju Arora, who are retiring by rotation, and the regularization of Mr. Swanith Kapoor as an Independent Director. Additionally, Mr. Aditya Arora's re-appointment as Whole Time Director for five years from September 30, 2026, was approved, along with the appointment of M/s Verma Khushwinder & Co. as Cost Auditors for FY27. Mr. Rishi Mittal will serve as the Scrutinizer for the e-voting process.
Key Highlights
- Board approved the 43rd Annual General Meeting notice and related calendar.
- AGM to be held on August 31, 2026, with e-voting facility available.
- Re-appointment of directors Mr. Aditya Arora and Mrs. Anju Arora approved.
- Regularization of Mr. Swanith Kapoor as Independent Director approved.
- Cost Auditors appointed for FY27; remuneration subject to AGM ratification.
Price Impact
More from KPL